Shalini Sharp Bei Gene, Ltd. (BGNE) insider trading activity

BGNE Quotes by TradingView

Shalini Sharp is Director of BeiGene, Ltd.. Currently has a direct ownership of 19,136 shares of BGNE, which is worth approximately $4.34 Million. The most recent transaction as insider was on May 21, 2025, when has been sold 10,985 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.1K
134.77% 3M change
n/a 12M change
Total Value Held $4.34 Million

Shalini Sharp Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2025
BUY
Grant, award, or other acquisition
-
10,985 Added 36.47%
19,136 Ordinary Shares
Sep 30 2024
BUY
Grant, award, or other acquisition
-
8,151 Added 50.0%
8,151 Ordinary Shares

Also insider at

RARE
Ultragenyx Pharmaceutical Inc. Healthcare
EVP, Finance
DTIL
PRECISION BIOSCIENCES INC Healthcare
Director
NUVB
Nuvation Bio Inc. Healthcare
Director
MRTX
Mirati Therapeutics, Inc. Healthcare
NBIX
NEUROCRINE BIOSCIENCES INC Healthcare
Director
STRO
SUTRO BIOPHARMA, INC. Healthcare
Director
OGN
Organon & Co. Healthcare
Director
SEPN
Septerna, Inc.
SS

Shalini Sharp

Director
San Diego, CA

Track Institutional and Insider Activities on BGNE

Follow BeiGene, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BGNE shares.

Notify only if

Insider Trading

Get notified when an Bei Gene, Ltd. insider buys or sells BGNE shares.

Notify only if

News

Receive news related to BeiGene, Ltd.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BGNE